This genetic insight helps your clinician determine whether semaglutide is your optimal starting medication or whether an alternative like tirzepatide may work better with your unique biochemistrymaking therapy more personalized and effective
Individuals undergoing GLP-1 therapy often experience reduced appetite, making it difficult to prepare or consume full meals
They shared with us the top reasons their clients may run into issues losing weight on Zepbound
Today, semaglutide is approved by the U.S
While medications such as Mounjaro may have specific timing requirements, Wegovy's timing flexibility makes it easier for patients to integrate the treatment into their weekly schedule, promoting better adherence and potentially improving treatment outcomes
This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet